Head of RWE Implementation and Innovation
Josh is the Head of RWE Implementation and Innovation for AcornAI, a Medidata Company and former Head of Clinical Products at SHYFT, a Medidata Company. He leads the development and implementation of big data & analytics software-as-a-solution (SaaS) platforms for the life sciences industry in the commercial and medical science areas. In addition, he has served leading pharmaceutical, biotechnology, and medical device companies focusing on innovation strategy, portfolio strategy, new product planning and launch, and personalized medicine strategy across commercial and R&D operations. Currently, Josh is focused on the design, creation, and deployment of an innovative, cloud-based, mobile analytics SaaS platform for aggregating, stratifying, analyzing and disseminating insights from real world evidence across clinical and commercial operations.
Prior to joining SHYFT, Josh was an Associate Director in Quintiles Consulting’s Emerging Technology Strategy practice and Precision Medicine subject matter expert. Prior to joining Quintiles, Josh was a Senior Associate with McKinsey & Company in their New Jersey office with a focus on innovation strategy and commercial strategy redesign.
Josh holds a PhD in Biomedical Sciences and Genetics from the University of Texas Southwestern Medical Center at Dallas in the lab of Deepak Srivastava, a BS in Biochemistry and a BA in Chemistry, both from North Carolina State University. While pursuing the PhD, Josh also performed research at the University of California, San Francisco / J David Gladstone Institutes. Josh has published multiple scientific papers on the topics of congenital heart malformations in top scientific journals such as Nature, Cell, and JBC.
Monday, September 23
4:00 PM – 5:30 PM